Woman Trial Txa

WOMAN Trial Collaborators. (2017). "Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial." The Lancet , 389(10084), 2105–2116.

The subsequent investigated the use of TXA for preventing PPH in women with moderate to severe anaemia. Unlike the original trial's treatment results, WOMAN-2 found that while anaemic women were at much higher risk for PPH, prophylactic TXA did not significantly reduce that risk in this specific population. woman trial txa